Projects

SHIP CT: A Phase 3 randomised, double-blind, controlled trial of inhaled 7% hypertonic saline versus 0.9% isotonic saline for 48 weeks in patients with Cystic Fibrosis at 3-6 years of age in parallel with the North American SHIP clinical trial.

SHIP-CT, led by Professor Stephen Stick, Director of the Wal-yan Respiratory Research Centre at The Kids, is a unique study in preschool-aged children (from 3-6 years of age) with CF using images of the lung from chest CT scans as the main outcome measure.

DEFEND CF: Biomarkers to define the treatment end-point for pulmonary exacerbations in cystic fibrosis

Sensitive and reliable tests are required to monitor lung disease severity in cystic fibrosis.

AREST CF Early Surveillance Program

The Early Surveillance Program (ESP) is the platform upon which the AREST CF research program is based.

COMBAT CF: A phase 3 multi-centre randomized placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis.

A phase 3 multi-centre randomized placebo-controlled study of azithromycin in the primary prevention of radiologically-defined bronchiectasis in infants with cystic fibrosis

The Facilitation of Acceptance in Trans and Gender Diverse Young People

Helen Yael Morgan Perry BA (Hons), Doctor of Psychology BPsych (Hons) MPsych (Clin) PhD Senior Project Coordinator Head, Youth Mental Health 08 6319 1298 Helen.Morgan@thekids.org.au yael.perry@thekids.org.au Senior Project Coordinator Head, Youth